marketcaparena
Search

    AGL

    agilon health, inc.

    Company overview

    Market capitalization
    $1.34B
    Employees
    856
    Latest publication
    2026-09-29
    About agilon health, inc.

    agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ1 20222022-03-31 · USDQ2 20202020-06-30 · USD
    Total Revenue1,494,743,000USD1,420,460,000USD653,445,000USD293,594,000USD
    Cost Of Revenue1,387,604,000USD1,362,232,000USD610,981,000USD255,124,000USD
    Gross Profit107,139,000USD58,228,000USD42,464,000USD38,470,000USD
    General And Administrative Expenses88,505,000USD———
    Total Operating Expenses95,369,000USD48,117,000USD43,207,000USD39,722,000USD
    Operating Income11,770,000USD10,111,000USD-743,000USD-1,252,000USD
    Total Other Income Expense Net5,811,000USD19,833,000USD1,398,000USD-2,154,000USD
    Interest Expense1,608,000USD1,811,000USD871,000USD2,080,000USD
    Depreciation And Amortization6,864,000USD6,787,000USD3,373,000USD3,482,000USD
    Income Before Tax17,581,000USD29,944,000USD655,000USD-3,406,000USD
    Income Tax Expense-375,000USD-28,000USD-71,000USD39,000USD
    Equity Method Income Loss-7,596,000USD———
    Net Income17,956,000USD29,972,000USD1,230,000USD-7,911,000USD
    Selling General Administrative—54,231,000USD39,834,000USD36,403,000USD
    Unclassified Operating Expenses—-6,114,000USD3,373,000USD3,319,000USD
    Net Interest Income—-1,811,000USD-871,000USD-2,080,000USD
    Tax Provision—28,000USD-71,000USD39,000USD
    Net Income From Continuing Ops—29,916,000USD726,000USD-3,445,000USD
    Ebit—28,133,000USD1,526,000USD-1,326,000USD
    Ebitda—34,920,000USD4,899,000USD2,156,000USD
    Reconciled Depreciation—6,787,000USD3,373,000USD3,482,000USD
    Interest Income——871,000USD2,080,000USD
    Minority Interest——75,000USD-73,000USD
    Discontinued Operations——429,000USD-4,466,000USD
    Net Income Applicable To Common Shares——1,230,000USD-7,911,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,591,336,000USD1,504,938,000USD1,271,290,000USD1,596,245,000USD1,712,895,000USD1,932,861,000USD1,733,983,000USD2,091,411,000USD
    Cash And Equivalents107,184,000USD—173,713,000USD171,684,000USD171,416,000USD136,941,000USD188,231,000USD148,161,000USD
    Total Current Assets1,418,534,000USD1,321,173,000USD1,096,697,000USD1,338,028,000USD1,452,660,000USD1,650,722,000USD1,457,774,000USD1,811,759,000USD
    Other Current Assets101,494,000USD190,017,000USD137,762,000USD80,017,000USD78,495,000USD42,353,000USD35,137,000USD44,854,000USD
    Other Non Current Assets88,157,000USD———————
    Total Liabilities1,363,809,000USD———————
    Total Current Liabilities1,312,349,000USD1,272,325,000USD1,076,485,000USD1,239,881,000USD1,249,088,000USD1,374,701,000USD1,152,006,000USD1,409,157,000USD
    Other Non Current Liabilities36,083,000USD———————
    Total Equity Including Noncontrolling Interest227,527,000USD———————
    Short Long Term Debt14,915,000USD14,746,000USD19,238,000USD34,966,000USD34,945,000USD34,924,000USD——
    Long Term Debt15,377,000USD15,279,000USD15,750,000USD0USD0USD0USD34,904,000USD34,884,000USD
    Property Plant Equipment Net24,513,000USD30,128,000USD25,417,000USD30,084,000USD36,238,000USD37,831,000USD36,952,000USD39,691,000USD
    Intangible Assets60,132,000USD62,446,000USD65,725,000USD75,254,000USD65,600,000USD68,187,000USD72,771,000USD73,412,000USD
    Accounts Payable274,928,000USD1,257,579,000USD1,057,247,000USD145,517,000USD1,214,143,000USD1,339,777,000USD1,149,546,000USD1,409,157,000USD
    Common Stock168,000USD166,000USD4,147,000USD4,146,000USD4,143,000USD4,130,000USD4,122,000USD4,120,000USD
    Retained Earnings-1,911,452,000USD-1,929,408,000USD-1,978,324,000USD-1,789,442,000USD-1,679,235,000USD-1,574,865,000USD-1,586,977,000USD-1,481,187,000USD
    Accumulated Other Comprehensive Income154,000USD479,000USD916,000USD880,000USD787,000USD543,000USD-88,000USD301,000USD
    Total Liab—1,323,505,000USD1,144,556,000USD1,290,168,000USD1,303,966,000USD1,432,607,000USD1,263,031,000USD1,516,539,000USD
    Total Stockholder Equity—181,433,000USD126,734,000USD306,077,000USD408,929,000USD500,254,000USD470,952,000USD574,872,000USD
    Other Current Liab—1,257,579,000USD1,057,247,000USD1,059,398,000USD1,214,143,000USD—-2,460,000USD1,409,157,000USD
    Capital Stock—166,000USD4,147,000USD4,146,000USD4,143,000USD4,130,000USD4,122,000USD4,120,000USD
    Cash—139,987,000USD173,713,000USD171,684,000USD171,416,000USD138,623,000USD193,860,000USD153,790,000USD
    Cash And Short Term Investments—231,411,000USD285,142,000USD310,854,000USD327,001,000USD368,766,000USD405,597,000USD398,556,000USD
    Net Debt—-106,587,000USD-136,898,000USD-134,563,000USD-130,043,000USD-96,604,000USD-149,897,000USD-109,888,000USD
    Short Term Debt—14,746,000USD19,238,000USD34,966,000USD34,945,000USD34,924,000USD2,460,000USD0USD
    Short Long Term Debt Total—33,400,000USD36,815,000USD37,121,000USD41,373,000USD42,019,000USD43,963,000USD43,902,000USD
    Long Term Investments—72,147,000USD59,787,000USD90,469,000USD77,906,000USD73,035,000USD61,756,000USD53,945,000USD
    Short Term Investments—91,424,000USD111,429,000USD139,170,000USD155,585,000USD230,143,000USD211,737,000USD244,766,000USD
    Net Receivables—899,745,000USD673,793,000USD947,157,000USD1,047,164,000USD1,239,603,000USD1,017,040,000USD1,368,349,000USD
    Property Plant Equipment Gross—30,128,000USD64,502,000USD62,984,000USD67,438,000USD65,243,000USD61,628,000USD61,597,000USD
    Common Stock Shares Outstanding—16,662,000shares16,584,680shares16,578,600shares16,553,440shares16,517,440shares16,481,760shares16,463,640shares
    Non Current Assets Total—183,765,000USD174,593,000USD258,217,000USD260,230,000USD282,139,000USD276,209,000USD279,652,000USD
    Non Current Liabilities Total—51,180,000USD68,071,000USD50,287,000USD54,878,000USD57,905,999USD111,024,999USD107,382,000USD
    Non Current Liabilities Other—32,526,000USD50,494,000USD48,132,000USD48,450,000USD50,811,000USD69,522,000USD63,480,000USD
    Non Currrent Assets Other—19,044,000USD23,664,000USD38,277,000USD56,353,000USD78,953,000USD80,597,000USD88,471,000USD
    Net Working Capital—48,848,000USD20,212,000USD98,147,000USD203,572,000USD276,021,000USD305,768,000USD402,602,000USD
    Unclassified Current Liabilities—-1,272,325,000USD-1,076,485,000USD-34,966,000USD-1,249,088,000USD-34,924,000USD—-1,409,157,000USD
    Unclassified Non Current Liabilities—3,375,000USD1,827,000USD2,155,000USD6,428,000USD7,094,999USD6,598,999USD9,018,000USD
    Unclassified Equity—2,110,030,000USD2,095,848,000USD2,086,347,000USD2,079,091,000USD2,066,316,000USD2,049,773,000USD2,047,518,000USD
    Good Will——0USD24,133,000USD24,133,000USD24,133,000USD24,133,000USD24,133,000USD
    Other Assets——20,122,000USD38,277,000USD5,000USD78,953,000USD80,597,000USD88,471,000USD
    Unclassified Non Current Assets——-20,122,000USD-38,277,000USD—-78,953,000USD-80,597,000USD-88,471,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Total Assets1,271,290,000USD1,733,983,000USD1,740,866,000USD1,697,468,000USD1,586,252,000USD446,361,000USD402,794,000USD
    Intangible Assets65,725,000USD72,771,000USD63,769,000USD18,448,000USD55,398,000USD60,468,000USD71,146,000USD
    Other Current Assets137,762,000USD35,137,000USD42,513,000USD81,707,000USD18,968,000USD42,847,000USD28,641,000USD
    Total Liab1,144,556,000USD1,263,031,000USD1,079,845,000USD656,859,000USD494,656,000USD731,091,000USD634,822,000USD
    Total Stockholder Equity126,734,000USD470,952,000USD661,839,000USD1,041,220,000USD1,091,896,000USD-284,730,000USD-232,028,000USD
    Other Current Liab1,057,247,000USD-2,460,000USD968,060,000USD51,865,000USD242,321,000USD3,682,000USD8,309,000USD
    Common Stock4,147,000USD4,122,000USD4,064,000USD4,124,000USD4,001,000USD2,494,000USD2,467,000USD
    Capital Stock4,147,000USD4,122,000USD4,064,000USD4,124,000USD4,001,000USD2,494,000USD2,467,000USD
    Retained Earnings-1,978,324,000USD-1,586,977,000USD-1,326,826,000USD-1,064,230,000USD-957,677,000USD-551,190,000USD-491,138,000USD
    Good Will0USD24,133,000USD24,133,000USD2,513,000USD41,540,000USD41,540,000USD41,540,000USD
    Other Assets20,122,000USD80,597,000USD1USD86,543,000USD225,916,000USD34,115,000USD25,744,000USD
    Cash173,713,000USD193,860,000USD114,329,000USD465,302,000USD1,054,819,999USD106,795,000USD123,633,000USD
    Cash And Equivalents173,713,000USD188,231,000USD107,570,000USD497,070,000USD1,040,039,000USD106,795,000USD123,633,000USD
    Cash And Short Term Investments285,142,000USD405,597,000USD495,102,000USD877,203,000USD1,054,819,999USD106,795,000USD123,633,000USD
    Total Current Assets1,096,697,000USD1,457,774,000USD1,480,076,000USD1,451,274,000USD1,367,195,000USD294,197,000USD245,528,000USD
    Total Current Liabilities1,076,485,000USD1,152,006,000USD977,156,000USD535,091,000USD356,960,000USD266,835,000USD199,610,000USD
    Net Debt-136,898,000USD-149,897,000USD-62,020,000USD-412,729,000USD-995,207,999USD-33,581,000USD-45,712,000USD
    Short Term Debt19,238,000USD2,460,000USD9,096,000USD5,000,000USD8,307,000USD3,041,000USD3,041,000USD
    Short Long Term Debt19,238,000USD—6,250,000USD5,000,000USD5,000,000USD3,041,000USD3,041,000USD
    Short Long Term Debt Total36,815,000USD43,963,000USD52,309,000USD52,573,000USD59,612,000USD73,214,000USD77,921,000USD
    Long Term Debt15,750,000USD34,904,000USD32,308,000USD38,482,000USD43,401,000USD64,665,000USD67,143,000USD
    Long Term Investments59,787,000USD61,756,000USD44,753,000USD17,352,000USD6,690,000USD8,502,000USD—
    Short Term Investments111,429,000USD211,737,000USD380,773,000USD411,901,000USD0USD——
    Net Receivables673,793,000USD1,017,040,000USD942,461,000USD492,364,000USD293,407,000USD144,555,000USD93,254,000USD
    Accounts Payable1,057,247,000USD1,149,546,000USD968,060,000USD478,226,000USD348,653,000USD260,112,000USD188,260,000USD
    Property Plant Equipment Net25,417,000USD36,952,000USD40,987,000USD31,953,000USD20,900,000USD16,041,000USD18,836,000USD
    Property Plant Equipment Gross64,502,000USD61,628,000USD55,305,000USD42,460,000USD29,105,000USD16,041,000USD18,836,000USD
    Accumulated Other Comprehensive Income916,000USD-88,000USD-2,298,000USD-5,560,000USD0USD-7,275,000USD-4,850,000USD
    Common Stock Shares Outstanding16,558,760shares16,438,640shares16,356,680shares16,326,160shares14,917,240shares15,393,456shares15,360,862shares
    Non Current Assets Total174,593,000USD276,209,000USD260,789,999USD246,194,000USD219,057,000USD152,164,000USD157,266,000USD
    Non Current Liabilities Total68,071,000USD111,024,999USD102,689,000USD121,768,000USD137,696,000USD464,256,000USD435,212,000USD
    Non Current Liabilities Other50,494,000USD69,522,000USD59,476,000USD83,286,000USD94,295,000USD74,574,000USD66,394,000USD
    Non Currrent Assets Other23,664,000USD80,597,000USD87,147,999USD175,928,000USD94,529,000USD25,613,000USD25,744,000USD
    Net Working Capital20,212,000USD305,768,000USD502,920,000USD916,183,000USD1,010,235,000USD27,362,000USD45,918,000USD
    Unclassified Non Current Assets-20,122,000USD-80,597,000USD—-86,543,000USD-225,916,000USD-34,115,000USD-25,744,000USD
    Unclassified Current Liabilities-1,076,485,000USD—-974,310,000USD—-247,321,000USD-3,041,000USD-3,041,000USD
    Unclassified Non Current Liabilities1,827,000USD6,598,999USD10,905,000USD-73,401,000USD-188,590,000USD-69,066,000USD-58,657,000USD
    Unclassified Equity2,095,848,000USD2,049,773,000USD1,982,835,000USD2,102,762,000USD2,041,571,000USD268,747,000USD259,026,000USD
    Current Deferred Revenue——-970,906,000USD-346,727,000USD-351,960,000USD——
    Inventory——-42,513,000USD10,610,000USD1USD1USD1USD
    Other Liab———73,401,000USD188,590,000USD394,083,000USD360,332,000USD
    Net Tangible Assets———932,000,000USD994,958,000USD-386,738,000USD-344,714,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Net Income-188,882,000USD-110,207,000USD-104,370,000USD12,112,000USD-105,790,000USD-126,846,000USD-30,662,000USD-6,034,000USD
    Depreciation6,969,000USD7,430,000USD7,319,000USD6,876,000USD6,494,000USD6,218,000USD5,907,000USD5,844,000USD
    Stock Based Compensation9,520,000USD7,498,000USD15,381,000USD16,720,000USD2,282,000USD13,259,000USD18,207,000USD16,909,000USD
    Other Non Cash Items69,190,000USD-15,597,000USD-6,290,000USD-28,901,000USD7,668,000USD32,354,000USD-8,192,000USD-1,160,000USD
    Change In Working Capital82,666,000USD92,722,000USD52,875,000USD-38,794,000USD105,765,000USD67,312,000USD-3,977,000USD-63,335,000USD
    Total Cash From Operating Activities-20,537,000USD-18,154,000USD-35,085,000USD-31,987,000USD16,419,000USD-7,703,000USD-18,717,000USD-47,776,000USD
    Capital Expenditures-17,036,000USD-3,175,000USD-3,250,000USD-10,883,000USD-12,423,000USD14,359,000USD-9,767,000USD-14,577,000USD
    Free Cash Flow-37,573,000USD-21,329,000USD-38,335,000USD-42,870,000USD3,996,000USD6,656,000USD-28,484,000USD-62,353,000USD
    Investments33,341,000USD18,658,000USD70,458,000USD-23,089,000USD23,673,000USD46,563,000USD18,217,000USD51,438,000USD
    Total Cashflows From Investing Activities22,583,000USD18,658,000USD70,458,000USD-23,089,000USD23,673,000USD46,563,000USD18,217,000USD51,438,000USD
    Net Borrowings0USD0USD0USD0USD0USD-1,250,000USD——
    Total Cash From Financing Activities-17,000USD-236,000USD-2,580,000USD-161,000USD-22,000USD-1,406,000USD-1,714,000USD559,000USD
    Sale Purchase Of Stock-17,000USD-236,000USD-2,580,000USD-161,000USD1,167,000USD464,000USD-464,000USD—
    Change In Cash2,029,000USD268,000USD32,793,000USD-55,237,000USD40,070,000USD37,454,000USD-2,214,000USD4,221,000USD
    Begin Period Cash Flow171,684,000USD171,416,000USD138,623,000USD193,860,000USD153,790,000USD116,336,000USD118,550,000USD114,329,000USD
    End Period Cash Flow173,713,000USD171,684,000USD171,416,000USD138,623,000USD193,860,000USD153,790,000USD116,336,000USD118,550,000USD
    Other Cashflows From Investing Activities-5,107,000USD-13,359,000USD-1,000,000USD-7,034,000USD-13,148,000USD-18,877,000USD-7,689,000USD-19,946,000USD
    Other Cashflows From Financing Activities-17,000USD-236,000USD-2,741,000USD——46,563,000USD18,217,000USD51,438,000USD
    Unclassified Investing Cash Flow11,385,000USD16,534,000USD4,250,000USD17,917,000USD25,571,000USD4,518,000USD17,456,000USD34,523,000USD
    Unclassified Financing Cash Flow——2,741,000USD—-1,189,000USD-47,183,000USD-19,467,000USD-52,688,000USD
    Issuance Of Capital Stock————-22,000USD-156,000USD-464,000USD1,809,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Net Income-391,347,000USD-260,101,000USD-262,803,000USD-106,864,000USD-406,787,000USD-60,052,000USD-282,740,000USD
    Depreciation28,594,000USD24,463,000USD20,161,000USD13,772,000USD14,670,000USD14,099,000USD41,413,000USD
    Stock Based Compensation49,119,000USD50,657,000USD69,326,000USD28,381,000USD292,394,000USD6,688,000USD5,225,000USD
    Other Non Cash Items18,402,000USD-3,385,000USD27,184,000USD-7,194,000USD9,820,000USD-17,602,000USD115,241,000USD
    Change To Account Receivables344,585,000USD-74,580,000USD-460,365,000USD-204,167,000USD-149,041,000USD-59,381,000USD-23,280,000USD
    Change In Working Capital189,469,000USD130,589,000USD-10,067,000USD-59,435,000USD-55,025,000USD6,472,000USD33,177,000USD
    Total Cash From Operating Activities-105,763,000USD-57,777,000USD-156,199,000USD-130,808,000USD-148,159,000USD-53,204,000USD-103,861,000USD
    Capital Expenditures-13,242,000USD-13,251,000USD-30,815,000USD-32,661,000USD-13,426,000USD-2,350,000USD-3,906,000USD
    Free Cash Flow-119,005,000USD-71,028,000USD-187,014,000USD-163,469,000USD-161,585,000USD-55,554,000USD-107,767,000USD
    Investments133,718,000USD139,891,000USD-49,786,000USD-412,227,000USD-75,736,000USD22,066,000USD-5,060,000USD
    Total Cashflows From Investing Activities88,610,000USD139,891,000USD-44,019,000USD-444,388,000USD-90,506,000USD22,066,000USD-5,060,000USD
    Net Borrowings0USD-3,750,000USD-5,000,000USD-5,000,000USD-34,638,000USD-3,041,000USD-3,592,000USD
    Total Cash From Financing Activities-2,994,000USD-2,583,000USD-193,133,000USD28,056,000USD1,154,390,000USD24,621,000USD176,298,000USD
    Sale Purchase Of Stock-2,994,000USD1,167,000USD-200,000,000USD33,056,000USD1,189,028,000USD-6,742,000USD180,193,000USD
    Change In Cash-20,147,000USD79,531,000USD-393,351,000USD-547,140,000USD915,725,000USD-6,517,000USD67,377,000USD
    Begin Period Cash Flow193,860,000USD114,329,000USD507,680,000USD1,054,820,000USD139,095,000USD145,612,000USD78,235,000USD
    End Period Cash Flow173,713,000USD193,860,000USD114,329,000USD507,680,000USD1,054,820,000USD139,095,000USD145,612,000USD
    Other Cashflows From Investing Activities-31,866,000USD-41,767,000USD-34,513,000USD-23,745,000USD-75,736,000USD-1,789,000USD-1,154,000USD
    Other Cashflows From Financing Activities-2,994,000USD-3,750,000USD-44,019,000USD33,056,000USD-14,739,000USD22,066,000USD-303,000USD
    Unclassified Financing Cash Flow2,994,000USD3,750,000USD62,753,000USD-33,056,000USD14,739,000USD12,338,000USD—
    Issuance Of Capital Stock—1,167,000USD13,842,000USD33,056,000USD1,170,942,000USD33,590,000USD180,193,000USD
    Unclassified Investing Cash Flow—55,018,000USD71,095,000USD24,245,000USD74,392,000USD4,139,000USD5,060,000USD
    Dividends Paid——-6,867,000USD————
    Change To Inventory———204,167,000USD149,041,000USD——
    Change To Liabilities———53,844,000USD17,662,000USD24,922,000USD18,451,000USD
    Cash And Cash Equivalents Changes———-547,140,000USD915,725,000USD——
    Unclassified Operating Cash Flow————-3,231,000USD-2,809,000USD-16,177,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductMedical Services1,492,921,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductOther Operating1,822,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductMedical Services1,418,549,000USD0001628280-26-031270
    Q1 2026Quarterly · 2026-03-31ProductOther Operating1,911,000USD0001628280-26-031270
    Q4 2025Quarterly · 2025-12-31ProductMedical Services1,566,986,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductOther Operating2,505,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductMedical Services5,921,341,000USD0001628280-26-011655
    FY 2025Yearly · 2025-12-31ProductOther Operating11,235,000USD0001628280-26-011655
    Q3 2025Quarterly · 2025-09-30ProductMedical Services1,432,437,000USD0001628280-25-048839
    Q3 2025Quarterly · 2025-09-30ProductOther Operating2,884,000USD0001628280-25-048839
    Q2 2025Quarterly · 2025-06-30ProductMedical Services1,392,039,000USD0001628280-25-037430
    Q2 2025Quarterly · 2025-06-30ProductOther Operating2,943,000USD0001628280-25-037430
    Q1 2025Quarterly · 2025-03-31ProductMedical Services1,529,879,000USD0001628280-26-031270
    Q1 2025Quarterly · 2025-03-31ProductOther Operating2,903,000USD0001628280-26-031270
    Q4 2024Quarterly · 2024-12-31ProductMedical Services1,519,244,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductOther Operating3,242,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductMedical Services6,047,715,000USD0001628280-26-011655
    FY 2024Yearly · 2024-12-31ProductOther Operating12,815,000USD0001628280-26-011655
    Q3 2024Quarterly · 2024-09-30ProductMedical Services1,447,697,000USD0001628280-25-048839
    Q3 2024Quarterly · 2024-09-30ProductOther Operating3,235,000USD0001628280-25-048839
    FY 2023Yearly · 2023-12-31ProductMedical Services4,307,350,000USD0001628280-26-011655
    FY 2023Yearly · 2023-12-31ProductOther Operating9,013,000USD0001628280-26-011655
    FY 2022Yearly · 2022-12-31ProductMedical Services2,384,889,000USD0001628280-25-007721
    FY 2022Yearly · 2022-12-31ProductOther Operating3,331,000USD0001628280-25-007721
    FY 2021Yearly · 2021-12-31ProductMedical Services Revenue1,518,322,000USD0001628280-24-007242
    FY 2021Yearly · 2021-12-31ProductProduct And Service Other3,172,000USD0001628280-24-007242
    FY 2020Yearly · 2020-12-31ProductMedical Services Revenue1,214,270,000USD0000950170-23-005541
    FY 2020Yearly · 2020-12-31ProductOther Operating Revenue4,063,000USD0000950170-23-005541
    FY 2019Yearly · 2019-12-31ProductMedical Services Revenue788,566,000USD0000950170-22-002826
    FY 2019Yearly · 2019-12-31ProductOther Operating Revenue5,845,000USD0000950170-22-002826

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.